These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 28643713

  • 21. Comparison between different techniques for treatment of submacular haemorrhage due to Age-Related Macular Degeneration.
    Kishikova L, Saad AAA, Vaideanu-Collins D, Isac M, Hamada D, El-Haig WM.
    Eur J Ophthalmol; 2021 Sep; 31(5):2621-2624. PubMed ID: 32993349
    [Abstract] [Full Text] [Related]

  • 22. TISSUE PLASMINOGEN ACTIVATOR FOR SUBFOVEAL HEMORRHAGE DUE TO AGE-RELATED MACULAR DEGENERATION: Comparison of 3 Treatment Modalities.
    Fassbender JM, Sherman MP, Barr CC, Schaal S.
    Retina; 2016 Oct; 36(10):1860-5. PubMed ID: 26945238
    [Abstract] [Full Text] [Related]

  • 23. [Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration].
    Auriol S, Mahieu L, Lequeux L, Quintyn JC, Pagot-Mathis V.
    J Fr Ophtalmol; 2010 Feb; 33(2):84-91. PubMed ID: 20092910
    [Abstract] [Full Text] [Related]

  • 24. Sequential tissue plasminogen activator, pneumatic displacement, and anti-VEGF treatment for submacular hemorrhage.
    Bardak H, Bardak Y, Erçalık Y, Erdem B, Arslan G, Timlioglu S.
    Eur J Ophthalmol; 2018 May; 28(3):306-310. PubMed ID: 29148027
    [Abstract] [Full Text] [Related]

  • 25. Tissue plasminogen activator-assisted vitrectomy: surgical drainage of submacular hemorrhage.
    Kamei M, Tano Y.
    Dev Ophthalmol; 2009 May; 44():82-88. PubMed ID: 19494655
    [Abstract] [Full Text] [Related]

  • 26. [Treatment of submacular hematoma by vitrectomy, subretinal injection of rtPA and gaseous tamponade: A single-center retrospective observational study].
    Berthon C, Rousseau E, Chiambaretta F.
    J Fr Ophtalmol; 2020 May; 43(5):417-426. PubMed ID: 32192752
    [Abstract] [Full Text] [Related]

  • 27. Fundus Autofluorescence Patterns in Subretinal Hemorrhages Associated with Neovascular Age-Related Macular Degeneration.
    Nawrocka ZA, Nawrocki J.
    Ophthalmologica; 2024 May; 247(1):58-64. PubMed ID: 38113868
    [Abstract] [Full Text] [Related]

  • 28. PREDICTORS OF 3-MONTH AND 1-YEAR VISUAL OUTCOMES AFTER VITRECTOMY WITH SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR INJECTION FOR SUBMACULAR HEMORRHAGE.
    Miki M, Miyata M, Ooto S, Tamura H, Ueda-Arakawa N, Muraoka Y, Miyake M, Hata M, Takahashi A, Kido A, Kogo T, Uji A, Tsujikawa A.
    Retina; 2023 Nov 01; 43(11):1971-1979. PubMed ID: 37490778
    [Abstract] [Full Text] [Related]

  • 29. Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage.
    Treumer F, Klatt C, Roider J, Hillenkamp J.
    Br J Ophthalmol; 2010 Jan 01; 94(1):48-53. PubMed ID: 19946027
    [Abstract] [Full Text] [Related]

  • 30. Subretinal Coapplication of Tissue Plasminogen Activator and Bevacizumab with Concurrent Pneumatic Displacement for Submacular Hemorrhages Secondary to Neovascular Age-Related Macular Degeneration.
    Avcı R, Mavi Yıldız A, Çınar E, Yılmaz S, Küçükerdönmez C, Akalp FD, Avcı E.
    Turk J Ophthalmol; 2021 Feb 25; 51(1):38-44. PubMed ID: 33631914
    [Abstract] [Full Text] [Related]

  • 31. Little effect of tissue plasminogen activator in subretinal surgery for acute hemorrhage in age-related macular degeneration.
    Hesse L, Meitinger D, Schmidt J.
    Ger J Ophthalmol; 1996 Nov 25; 5(6):479-83. PubMed ID: 9479539
    [Abstract] [Full Text] [Related]

  • 32. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator.
    Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG.
    Graefes Arch Clin Exp Ophthalmol; 2010 Jan 25; 248(1):5-11. PubMed ID: 19669780
    [Abstract] [Full Text] [Related]

  • 33. Intravitreal Recombinant Tissue Plasminogen Activator and Sulphur Hexafluoride Gas for Submacular Haemorrhage Displacement in Age-Related Macular Degeneration: Looking behind the Blood.
    Maggio E, Peroglio Deiro A, Mete M, Sartore M, Polito A, Prigione G, Guerriero M, Pertile G.
    Ophthalmologica; 2020 Jan 25; 243(3):224-235. PubMed ID: 31905361
    [Abstract] [Full Text] [Related]

  • 34. VITRECTOMY WITH SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR AND GAS TAMPONADE FOR SUBFOVEAL HEMORRHAGE: Prognostic Factors and Clinical Outcomes.
    Plemel DJA, Lapere SRJ, Rudnisky CJ, Tennant MTS.
    Retina; 2019 Jan 25; 39(1):172-179. PubMed ID: 29135798
    [Abstract] [Full Text] [Related]

  • 35. Retinal sensitivity after displacement of submacular hemorrhage due to polypoidal choroidal vasculopathy: effectiveness and safety of subretinal tissue plasminogen activator.
    Kimura S, Morizane Y, Matoba R, Hosokawa M, Shiode Y, Hirano M, Doi S, Toshima S, Takahashi K, Hosogi M, Fujiwara A, Shiraga F.
    Jpn J Ophthalmol; 2017 Nov 25; 61(6):472-478. PubMed ID: 28836011
    [Abstract] [Full Text] [Related]

  • 36. Vitrectomy and subretinal injection of tissue plasminogen activator for large submacular hemorrhage secondary to AMD.
    Moisseiev E, Ben Ami T, Barak A.
    Eur J Ophthalmol; 2014 Nov 25; 24(6):925-31. PubMed ID: 24966031
    [Abstract] [Full Text] [Related]

  • 37. Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator.
    Kimura S, Morizane Y, Hosokawa M, Shiode Y, Kawata T, Doi S, Matoba R, Hosogi M, Fujiwara A, Inoue Y, Shiraga F.
    Am J Ophthalmol; 2015 Apr 25; 159(4):683-9. PubMed ID: 25555798
    [Abstract] [Full Text] [Related]

  • 38. Treatment of hematomas in age related macular degeneration by vitrectomy and subretinal injection of r-tPA: Preliminary results.
    Boiché M, Angioi-Duprez K, Conart JB, Berrod JP.
    J Fr Ophtalmol; 2019 Nov 25; 42(9):e391-e397. PubMed ID: 31471124
    [Abstract] [Full Text] [Related]

  • 39. INTRAVITREAL VERSUS SUBRETINAL ADMINISTRATION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR COMBINED WITH GAS FOR ACUTE SUBMACULAR HEMORRHAGES DUE TO AGE-RELATED MACULAR DEGENERATION: An Exploratory Prospective Study.
    de Jong JH, van Zeeburg EJ, Cereda MG, van Velthoven ME, Faridpooya K, Vermeer KA, van Meurs JC.
    Retina; 2016 May 25; 36(5):914-25. PubMed ID: 26807631
    [Abstract] [Full Text] [Related]

  • 40. Vitrectomy with subretinal tissue plasminogen activator and ranibizumab for submacular haemorrhages secondary to age-related macular degeneration: retrospective case series of 45 consecutive cases.
    González-López JJ, McGowan G, Chapman E, Yorston D.
    Eye (Lond); 2016 Jul 25; 30(7):929-35. PubMed ID: 27055681
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.